05 October 2012 14:32 [Source: ICIS news]
Kley, who is CEO of Germany’s specialty chemicals and pharmaceuticals firm Merck KGaA, succeeds Klaus Engel. Engel, CEO of specialty chemicals producer Evonik, will stay on as a vice president of Frankfurt-based VCI.
Kley’s term as VCI president will expire in October 2014.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections